Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
326.60    -4.00 (-1.21%)
Bid:
326.20
Ask:
326.60
Spread: 0.40 (0.123%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Director/PDMR Shareholding

15 Dec 2025 15:00

RNS Number : 6126L
Hammerson PLC
15 December 2025
 

HAMMERSON PLC ("Hammerson" or the "Company")

 

TRANSACTIONS IN SHARES BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMRS")

 

15 DECEMBER 2025

 

Following the appointment of Rob Wilkinson as Chief Executive Officer Designate on 15 December 2025, and as Chief Executive Officer with effect from 1 January 2026, share awards pursuant to Listing Rule 9.3.2 have been made to Rob over ordinary shares of 5 pence each in Hammerson, to compensate him for remuneration arrangements forfeited on leaving his former employer. As set out in the announcement released on 9 September 2025 confirming Rob's appointment, the forfeited remuneration arrangement subject to the compensatory Hammerson buyout award relates to the annual bonuses (including deferred bonuses) for 2023, 2024, 2025 and 2026 Rob forfeited on leaving his former employer. The awards will vest and become exercisable in March of 2026, 2027, 2028 and 2029 respectively.

 

The price used to calculate the number of shares awarded was £3.1366 per share, this being the Company's average closing share price over the ten business days from 1 December 2025 to 12 December 2025 inclusive.

 

All remuneration arrangements are consistent with the terms of the Directors' Remuneration Policy approved by shareholders at the Company's AGM in May 2023.

 

The following disclosure is made in accordance with UK MAR.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Robert Wilkinson

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer Designate / PDMR

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Hammerson plc

b)

 

LEI

 

213800G1C9KKVVDN1A60

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each ("Shares")

 

 

 

ISIN: GB00BRJQ8J25

b)

 

Nature of the transaction

 

 

Awards of nil cost options pursuant to Listing Rule 9.3.2. Performance conditions do not apply to these awards.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume

Vesting date

£0.00

 153,350

15 March 2026

£0.00

 86,399

15 March 2027

£0.00

 55,792

15 March 2028

£0.00

 28,693

15 March 2029

d)

 

Aggregated information

- Aggregated volume

- Price

 

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

324,234

£0.00

 

 

e)

 

Date of the transaction

 

15 December 2025

f)

 

Place of the transaction

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAASFFPSFFA
Date   Source Headline
8th Jun 202612:15 pmRNSAdmission to Trading
8th Jun 202611:00 amRNSDirector/PDMR Shareholding
5th Jun 20268:00 amRNSPublication of Final Terms
2nd Jun 20267:00 amRNSSuccessful pricing of 5-year EUR350m bond
29th May 20263:45 pmRNSHolding(s) in Company
26th May 202610:00 amRNSResults of Dividend Reinvestment Plan
22nd May 20264:15 pmRNSDirector/PDMR Shareholding
19th May 20262:00 pmRNSDirector/PDMR Shareholding
15th May 202612:30 pmRNSDirector/PDMR Shareholding
14th May 20263:00 pmRNSDirector/PDMR Shareholding
30th Apr 20264:30 pmRNSTotal Voting Rights
30th Apr 202611:15 amRNSResult of AGM
30th Apr 20267:00 amRNSHammerson CFO to retire
29th Apr 20267:00 amRNSHolding(s) in Company
28th Apr 20263:00 pmRNSDirector/PDMR Shareholding
24th Apr 20261:30 pmRNSEMTN Programme: Publication of Base Prospectus
24th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
8th Apr 20264:00 pmRNSDirector/PDMR Shareholding
7th Apr 202612:45 pmRNSTotal Voting Rights and Capital
30th Mar 202610:00 amRNSDirector/PDMR Shareholding
26th Mar 202611:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Mar 20262:00 pmRNSDirector/PDMR Shareholding
17th Mar 202610:00 amRNSDirector/PDMR Shareholding
17th Mar 20269:00 amRNSDividend Currency Conversion Announcement
25th Feb 20267:01 amRNSDividend Declaration
25th Feb 20267:00 amRNSFinal Results
6th Feb 20267:00 amRNSDirectorate change
28th Jan 20269:00 amRNSNotice of Results
20th Jan 20263:30 pmRNSHolding(s) in Company
22nd Dec 202511:30 amRNSDirector/PDMR Shareholding
22nd Dec 20259:30 amRNSDirector/PDMR Shareholding
15th Dec 20253:00 pmRNSDirector/PDMR Shareholding
11th Dec 20252:15 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSDirectorate change
21st Nov 20257:00 amRNSAcquisition of The Oracle and Trading Update
13th Nov 20251:45 pmRNSDirector/PDMR Shareholding
31st Oct 20257:45 amRNSResults of Dividend Reinvestment Plan
28th Oct 20251:00 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 202511:00 amRNSDirector/PDMR Shareholding
22nd Oct 20254:30 pmRNSDirector/PDMR Shareholding
21st Oct 202512:00 pmRNSDirector/PDMR Shareholding
16th Oct 20251:00 pmRNSPublication of Final Terms
9th Oct 20257:00 amRNSBond Pricing, Guidance & Operational Update
25th Sep 20254:30 pmRNSHolding(s) in Company
19th Sep 20253:30 pmRNSDirector/PDMR Shareholding
11th Sep 20254:45 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNSAppointment of Rob Wilkinson as CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.